US FDA approves Adaptimmune therapy for a rare type of cancer

The US Food and Drug Administration (FDA) announced that it has approved Adaptimmune, a pioneering treatment for a rare type of soft tissue cancer that usually affects young adults.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM